{
  "ticker": "NMRA",
  "company_name": "Neumora Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06546995",
      "title": "Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Alzheimer's Disease, Healthy Elderly",
      "start_date": "2024-07-09",
      "completion_date": "2025-11-19",
      "enrollment": 0,
      "sponsor": "Neumora Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06029426",
      "title": "Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Major Depressive Disorder",
      "start_date": "2023-09-20",
      "completion_date": "2025-01-15",
      "enrollment": 0,
      "sponsor": "Neumora Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06029439",
      "title": "Study to Assess the Safety and Effectiveness of NMRA-335140-501",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Major Depressive Disorder",
      "start_date": "2023-11-10",
      "completion_date": "2027-06",
      "enrollment": 0,
      "sponsor": "Neumora Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06429722",
      "title": "To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Major Depressive Episode Associated With Bipolar II Disorder",
      "start_date": "2024-05-13",
      "completion_date": "2025-05-30",
      "enrollment": 0,
      "sponsor": "Neumora Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06058013",
      "title": "Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Major Depressive Disorder",
      "start_date": "2023-12-20",
      "completion_date": "2026-06",
      "enrollment": 0,
      "sponsor": "Neumora Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04221230",
      "title": "Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Major Depressive Disorder",
      "start_date": "2020-01-03",
      "completion_date": "2022-06-23",
      "enrollment": 0,
      "sponsor": "Neumora Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06058039",
      "title": "Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Major Depressive Disorder",
      "start_date": "2023-12-21",
      "completion_date": "2026-03",
      "enrollment": 0,
      "sponsor": "Neumora Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1": 1,
      "PHASE3": 4,
      "PHASE2": 2
    },
    "by_status": {
      "COMPLETED": 4,
      "RECRUITING": 3
    },
    "active_trials": 3,
    "completed_trials": 4,
    "conditions": [
      "Alzheimer's Disease, Healthy Elderly",
      "Major Depressive Disorder",
      "Major Depressive Episode Associated With Bipolar II Disorder"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:18.383579",
    "search_query": "Neumora Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Neumora+Therapeutics,+Inc."
  }
}